Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Meanwhile, AKRO is at 2.4B$ market cap

<< Previous

Bullboard Posts

Next >>

Post by Joemareon Jan 13, 2023 9:55am

228 Views

Post# 35220813

Meanwhile, AKRO is at 2.4B$ market cap

So so so bitter than the super executives and the super board of TH dropped the ball on this one.
Embarassing. They posted on linked-in they were at JPMorgan. Wonder how many really productive, business-moving meetings they had with 'partners' and others.

<< Previous

Bullboard Posts

Next >>

Voyageur Pharmaceuticals signs $2.6M contract in Latin America